ArticleJournal for immunotherapy of cancer2025
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma.
Ramya Ramaswami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleJournal for immunotherapy of cancer2025
Ramya Ramaswami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.